跳至主要内容
临床试验/IRCT20181118041689N1
IRCT20181118041689N1尚未招募3 期

Evaluating the effect of co-administration of melatonin and atorvastatin in type II diabetic patients with microalbuminuria

Iran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • Patients with type II diabetes
  • Diabetic patient over 40 years of age.
  • Patients with microalbuminuria (urinary albumin 30- 300 mg/24h)
  • Patients who sign a written informed consent form.
  • Patients with HbA1c of < 8%

排除标准

  • Patients with blood pressure > 160 / 90 mmHg
  • Patients with statins intolerance.
  • Patients with statin-inducedmyopathy
  • Patients who have used immunosuppressive drugs within 3 months of the first screening visit.
  • Patients with intolerance to blood pressure reducing drugs (e.g., angiotensin II receptor-blocking drugs)
  • Patients with other illness likely to influence the trial such as congestive heart failure, hypothyroidism, severe kidney failure, polycystic kidney disease, HIV nephropathy, ischemic kidney disease, interstitial nephritis of idiopathic kidney and hepatic failure
  • Patients who have been kidney transplant in the past.
  • Patients who have taken part in other clinical trials in the last 3 months.
  • Patients who are pregnant or breast-feeding.
  • Patients who are researchers and co-workers in this trial.
  • Patients with a history of alcohol abuse or smoking.

研究者

相似试验